Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety, Patient Safety in Surgery

Por um escritor misterioso
Last updated 15 junho 2024
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily dose of 300 mg on occasion. We report a case in which hypertension occurring after an abdominal aortic aneurysm repair, initially responsive to intermittent intravenous beta-blockade, became resistant to this therapy leading to the choice of an intravenous labetalol infusion as the therapeutic option. The labetalol infusion resulted in a profound cardiovascular compromise in this postoperative critically ill patient. While infusions of labetalol have successfully been used, prolonged administration in the intensive care unit requires vigilance and the establishment of a therapeutic rationale/policy for interventions, such as the ready availability of glucagon, β-agonists, phosphodiesterase inhibitors, insulin, and vasopressin when severe cardiovascular depression occurs.
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
PDF) Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Labetalol: Package Insert
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Frontiers Beta-Adrenergic Blockade in Critical Illness
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Hemodynamic Safety of Continuous Infusion Labetalol Versus Esmolol Combination Therapies for Type B Aortic Dissections
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5 - ScienceDirect
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
LABETALOL HYDROCHLORIDE injection
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Carvedilol Among Patients With Heart Failure With a Cocaine-Use Disorder
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Comparing Labetalol and Nitroglycerine on Inducing Controlled Hypotension and Intraoperative Blood Loss in Rhinoplasty: A Single-Blinded Clinical Trial, Anesthesiology and Pain Medicine
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
PDF] Managing Hypertension in Patients With Stroke Are You Prepared for Labetalol Infusion
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
LABETALOL HYDROCHLORIDE tablet, film coated
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Full article: Remifentanil versus labetalol for deliberate hypotensive anesthesia in children undergoing cochlear implantation: A randomized clinical trial

© 2014-2024 rahh.de. All rights reserved.